Business Description
SILO Pharma Inc
NAICS : 541713
SIC : 8731
ISIN : US73052R1041
Description
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.8 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -0.39 | |||||
| Beneish M-Score | -4.03 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 13.5 | |||||
| 3-Year EPS without NRI Growth Rate | 20.2 | |||||
| 3-Year FCF Growth Rate | -6.1 | |||||
| 3-Year Book Growth Rate | 41.4 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.95 | |||||
| 9-Day RSI | 45.45 | |||||
| 14-Day RSI | 48.77 | |||||
| 6-1 Month Momentum % | 47.33 | |||||
| 12-1 Month Momentum % | -8.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.9 | |||||
| Quick Ratio | 9.9 | |||||
| Cash Ratio | 9.88 | |||||
| Days Payable | 52377.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.5 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 94.44 | |||||
| Operating Margin % | -5354.17 | |||||
| Net Margin % | -5138.89 | |||||
| FCF Margin % | -4479.17 | |||||
| ROE % | -44.31 | |||||
| ROA % | -37.26 | |||||
| ROIC % | -2753.57 | |||||
| ROC (Joel Greenblatt) % | -1347.96 | |||||
| ROCE % | -39.5 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 73.8 | |||||
| PB Ratio | 0.88 | |||||
| Price-to-Tangible-Book | 0.88 | |||||
| EV-to-EBIT | 0.64 | |||||
| EV-to-EBITDA | 0.64 | |||||
| EV-to-Revenue | -32.21 | |||||
| EV-to-FCF | 0.72 | |||||
| Price-to-Net-Current-Asset-Value | 0.9 | |||||
| Price-to-Net-Cash | 0.9 | |||||
| Earnings Yield (Greenblatt) % | 156.25 | |||||
| FCF Yield % | -60.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SILO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SILO Pharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.072 | ||
| EPS (TTM) ($) | -1.2 | ||
| Beta | 0.5 | ||
| Volatility % | 34.11 | ||
| 14-Day RSI | 48.77 | ||
| 14-Day ATR ($) | 0.167434 | ||
| 20-Day SMA ($) | 1.95985 | ||
| 12-1 Month Momentum % | -8.1 | ||
| 52-Week Range ($) | 1.2162 - 3.05 | ||
| Shares Outstanding (Mil) | 2.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SILO Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SILO Pharma Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
SILO Pharma Inc Frequently Asked Questions
What is SILO Pharma Inc(SILO)'s stock price today?
The current price of SILO is $1.88. The 52 week high of SILO is $3.05 and 52 week low is $1.22.
When is next earnings date of SILO Pharma Inc(SILO)?
The next earnings date of SILO Pharma Inc(SILO) is .
Does SILO Pharma Inc(SILO) pay dividends? If so, how much?
SILO Pharma Inc(SILO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers